Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Dec 6, 2024; 12(34): 6696-6704
Published online Dec 6, 2024. doi: 10.12998/wjcc.v12.i34.6696
Table 2 Survival and mortality rate associated with benign and malignant lesions (n = 51)



n (%)
Died
Survived
P value
Malignant tumors (n = 37)GIST (n = 14)Gastrointestinal stromal tumor14 (27.5)0 (0.0)14 (100.0)0.015a
Non-GIST (n = 23)Adenocarcinoma9 (17.6)4 (44.4)5 (55.6)
Lymphoma8 (15.7)2 (25.0)6 (75.0)
Neuroendocrine tumor2 (3.9)0 (0.0)2 (0.0)
Sarcomatoid carcinoma2 (3.9)1 (50.0)1 (50.0)
Metastatic tumors12 (3.9)1 (50.0)1 (50.0)
Benign tumors (n = 14)14 (25.5)0 (0.0)14 (100.0)